CN Stock MarketDetailed Quotes

600223 Lushang Freda Pharmaceutical

Watchlist
  • 7.52
  • +0.20+2.73%
Market Closed Mar 11 15:00 CST
7.64BMarket Cap32.27P/E (TTM)

Lushang Freda Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Lushang Freda Pharmaceutical FY2024 Estimates Date

Currency：CNYMar 22, 2025

Estimate YoY
Revenue
4.15B
-9.44%
EPS
0.28
-5.40%
Analyst Rating
Strong Buy

Mar 11, 2025

Lushang Freda Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 8 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 4.766B--
Mar 22, 20252024/FY-- / 4.147B--
Mar 22, 20242023/FY4.579B / 4.544B--
Mar 31, 20232022/FY12.951B / 12.040B--
--2021/FY12.363B / 15.184B--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 4.766B--
Mar 22, 20252024/FY-- / 4.147B--
Mar 22, 20242023/FY4.579B / 4.544B--
Mar 31, 20232022/FY12.951B / 12.040B--
--2021/FY12.363B / 15.184B--

Unlock Free Earnings Estimates

Lushang Freda Pharmaceutical Earnings Reports

  • Freda: Report of Lushang Freda Pharmaceutical Co., Ltd. for the third quarter of 2024

    Oct 28, 2024 12:00 ET

  • Announcement of Lushang Freda Pharmaceutical Co., Ltd. on the main operating data for the third quarter of 2024

    Oct 28, 2024 12:00 ET

  • Lushang Freda Pharmaceutical Co., Ltd. Report for the Third Quarter of 2024

    Oct 28, 2024 12:00 ET

  • Lushang Freda Pharmaceutical Co., Ltd. 2024 Interim Report

    Aug 23, 2024 12:00 ET

    • Read more

    Top CN Stock Gainers
    Symbol Price % Chg
    Hanshow Technology
    301275
    66.92 +143.35%
    Yong Jie New Material
    603271
    46.23 +124.42%
    ZZT
    873726
    38.71 +29.99%
    BEOKA
    870199
    36.98 +23.76%
    Geovis Insighter Technology
    920116
    126.20 +21.91%

    See the daily top gainer.

    Analysis

    Analyst Rating

    Updated: Mar 11, 2025

    Strong Buy

    • Strong Buy

      67.74%

    • Buy

      32.26%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Investment Theme Cosmetics Concept
    Cosmetics Concept
    Intraday+2.33%
    Medical Beauty Concept
    Medical Beauty Concept
    Intraday+1.47%
    State-owned Enterprise Reform
    State-owned Enterprise Reform
    Intraday+0.60%